We are very pleased with the broadening of our innovative pipeline in renal medicine which now spans programs in AMKD, IgAN, pMN and polycystic kidney disease,” said Carmen Bozic, M.D., Executive Vice ...
Good day, and welcome to QuantumScape's third quarter 2024 earnings conference call. John Saager, QuantumScape's Vice President of Capital Markets and FP&A, you may begin your conference.